Krebs Biochemicals and Industries Ltd
KREBSBIOKrebs Biochemicals and Industries Ltd
KREBSBIO
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -9.78 | 19.75 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.92 | 6.65 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Krebs Biochemicals and Industries Limited is engaged in the business of manufacture of active pharmaceutical ingredients. The Company is producing a number of pain killers, anti-asthmatic and anti-human immunodeficiency virus (HIV) drugs.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3.88 | 3.65 | 34.13 | 48.20 | 33.78 | 54.32 | 60.86 | 52.75 | 50.87 | 51.05 | ||||||||||
Raw Materials | 1.77 | 1.34 | 17.12 | 20.99 | 19.18 | 25.62 | 46.18 | 19.81 | 5.52 | 60.82 | ||||||||||
| Power & Fuel Cost | 2.87 | 0.70 | 8.62 | 11.70 | 10.28 | 15.91 | 22.23 | 14.80 | 22.01 | |||||||||||
| Employee Cost | 5.67 | 5.63 | 11.49 | 14.41 | 14.56 | 15.30 | 14.96 | 15.54 | 16.17 | |||||||||||
| Selling & Administrative Expenses | 3.13 | 2.52 | 3.43 | 3.83 | 4.01 | 3.39 | 6.11 | 4.57 | 4.50 | |||||||||||
| Operating & Other expenses | 1.52 | 1.78 | 1.98 | 6.59 | 3.94 | 11.05 | 4.22 | 13.20 | 10.95 | |||||||||||
EBITDA | -11.08 | -8.32 | -8.51 | -9.32 | -18.19 | -16.95 | -32.84 | -15.17 | -8.28 | -9.77 | ||||||||||
| Depreciation/Amortization | 4.49 | 4.23 | 4.15 | 4.40 | 4.68 | 5.12 | 6.30 | 6.56 | 6.77 | 6.80 | ||||||||||
| PBIT | -15.57 | -12.55 | -12.66 | -13.72 | -22.87 | -22.07 | -39.14 | -21.73 | -15.05 | -16.57 | ||||||||||
| Interest & Other Items | 0.74 | 3.49 | 5.17 | 6.29 | 6.00 | 6.28 | 5.39 | 2.97 | 4.69 | 5.20 | ||||||||||
| PBT | -16.31 | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -19.74 | -21.77 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -16.31 | -16.04 | -17.83 | -20.01 | -28.87 | -28.35 | -44.53 | -24.70 | -19.74 | -21.77 | ||||||||||
| EPS | -13.95 | -11.56 | -12.53 | -12.97 | -16.67 | -15.07 | -21.63 | -11.46 | -9.16 | -10.10 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krebs Biochemicals and Industries Ltd | -10.79 | 19.75 | — |
| Sun Pharmaceutical Industries Ltd | 45.12 | 6.44 | 0.75% |
| Cipla Ltd | 28.85 | 4.44 | 0.88% |
| Torrent Pharmaceuticals Ltd | 69.10 | 16.69 | 0.83% |
Price Comparison
Compare KREBSBIO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
KREBSBIO has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeUflex Ltd, Raghav Productivity Enhancers Ltd, Ruby Mills Ltd and Shree Rama Multi-Tech Ltd are among the other losers in the BSE's 'B' group today, 28 November 2024.Krebs Biochemicals & Industries Ltd tumbled 10.00% to Rs 112.86 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 15166 shares were traded on the counter so far as against the average daily volumes of 15331 shares in the past one month.Uflex Ltd crashed 6.75% to Rs 540.05. The stock was the second biggest loser in 'B' group.On the BSE, 15520 shares were traded on the counter so far as against the average daily volumes of 5142 shares in the past one month.Raghav Productivity Enhancers Ltd lost 6.20% to Rs 1559.5. The stock was the third biggest loser in 'B' group.On the BSE, 9936 shares were traded on the counter so far as against the average daily volumes of 7019 shares in the past one month.Ruby Mills Ltd shed 5.32% to Rs 271.4. The stock was the fourth biggest loser in 'B' group.On the BSE, 4250 shares were traded on the counter so far as against the average daily volumes of 5650 shares in the past one month.Shree Rama Multi-Tech Ltd fell 5.00% to Rs 47.32. The stock was the fifth biggest loser in 'B' group.On the BSE, 2.49 lakh shares were traded on the counter so far as against the average daily volumes of 1.68 lakh shares in the past one month.Powered by Capital Market - Live
Ruby Mills Ltd, 3P Land Holdings Ltd, Godavari Biorefineries Ltd and RPP Infra Projects Ltd are among the other gainers in the BSE's 'B' group today, 26 November 2024.Krebs Biochemicals & Industries Ltd spiked 19.99% to Rs 118.23 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 74997 shares were traded on the counter so far as against the average daily volumes of 7351 shares in the past one month. Ruby Mills Ltd surged 19.99% to Rs 249.1. The stock was the second biggest gainer in 'B' group. On the BSE, 15233 shares were traded on the counter so far as against the average daily volumes of 1676 shares in the past one month. 3P Land Holdings Ltd soared 19.99% to Rs 65.73. The stock was the third biggest gainer in 'B' group. On the BSE, 24431 shares were traded on the counter so far as against the average daily volumes of 7340 shares in the past one month. Godavari Biorefineries Ltd advanced 17.00% to Rs 328.9. The stock was the fourth biggest gainer in 'B' group. On the BSE, 92054 shares were traded on the counter so far as against the average daily volumes of 1.03 lakh shares in the past one month. RPP Infra Projects Ltd spurt 16.53% to Rs 194.25. The stock was the fifth biggest gainer in 'B' group. On the BSE, 93348 shares were traded on the counter so far as against the average daily volumes of 13019 shares in the past one month. Powered by Capital Market - Live
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.76 crore in the quarter ended September 2024 as against net loss of Rs 3.57 crore during the previous quarter ended September 2023. Sales declined 13.63% to Rs 12.86 crore in the quarter ended September 2024 as against Rs 14.89 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.8614.89 -14 OPM %-21.15-6.04 - PBDT-4.05-1.86 -118 PBT-5.76-3.57 -61 NP-5.76-3.57 -61 Powered by Capital Market - Live
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2024Powered by Capital Market - Live
Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Net Loss of Krebs Biochemicals & Industries reported to Rs 5.17 crore in the quarter ended June 2024 as against net loss of Rs 5.33 crore during the previous quarter ended June 2023. Sales rose 21.83% to Rs 12.89 crore in the quarter ended June 2024 as against Rs 10.58 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales12.8910.58 22 OPM %-16.99-24.76 - PBDT-3.48-3.68 5 PBT-5.17-5.33 3 NP-5.17-5.33 3 Powered by Capital Market - Live
Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 7 August 2024.Powered by Capital Market - Live
Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group
North Eastern Carrying Corporation Ltd, Capital Trust Ltd, Kilitch Drugs (India) Ltd and Gujarat Raffia Industries Ltd are among the other gainers in the BSE's 'B' group today, 19 July 2024.Krebs Biochemicals & Industries Ltd soared 16.09% to Rs 118.84 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.47 lakh shares were traded on the counter so far as against the average daily volumes of 14701 shares in the past one month. North Eastern Carrying Corporation Ltd spiked 15.10% to Rs 36.06. The stock was the second biggest gainer in 'B' group. On the BSE, 4.15 lakh shares were traded on the counter so far as against the average daily volumes of 1.53 lakh shares in the past one month. Capital Trust Ltd surged 14.60% to Rs 136.95. The stock was the third biggest gainer in 'B' group. On the BSE, 85581 shares were traded on the counter so far as against the average daily volumes of 5237 shares in the past one month. Kilitch Drugs (India) Ltd exploded 10.00% to Rs 361.95. The stock was the fourth biggest gainer in 'B' group. On the BSE, 15931 shares were traded on the counter so far as against the average daily volumes of 1726 shares in the past one month. Gujarat Raffia Industries Ltd gained 9.99% to Rs 53.38. The stock was the fifth biggest gainer in 'B' group. On the BSE, 5819 shares were traded on the counter so far as against the average daily volumes of 5167 shares in the past one month. Powered by Capital Market - Live
Krebs Biochemicals & Industries Ltd leads gainers in ‘B’ group
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 1.08%, vs industry avg of 9.03%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.02% to 0.01%